Appointed
Brian Heckathorne
director
TGNT ·
Totaligent, Inc.
Effective April 18, 2025, the Board of Directors of the Company elected Brian Heckathorne to serve as a director.
Executive movement radar
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 7201–7250 of 76368
Departed
Stephanie Reed
Director
TBN ·
Tamboran Resources Corp
On April 15, 2025, Ms. Stephanie Reed notified the Board of Directors (the “Board”) of Tamboran Resources Corporation (the “Company”) of her intent to resign from the Board effective immediately.
Role change
Michael Jansen
Chief Financial Officer
Titan Environmental Solutions Inc.
On April 15, 2025, the Company terminated Michael Jansen as the Company’s Chief Financial Officer.
Appointed
Anna Skowron
Chief Financial Officer and Secretary
Titan Environmental Solutions Inc.
On April 15, 2025, Titan Environmental Solutions Inc. (the “ Company ”) appointed Anna Skowron as the Company’s Chief Financial Officer and Secretary, effective immediately.
Departed
Peter Salzmann
Member of Board of Directors
IMVT ·
Immunovant, Inc.
and as a member of the Company’s Board of Directors (the “Board”), effective April 18, 2025.
Appointed
Robert Susman
Member of Board of Directors
IMVT ·
Immunovant, Inc.
the Board appointed Robert Susman and Jacob Bauer to fill the vacancies on the Board created by the departure of each of Dr. Salzmann and Mr. Migausky
Appointed
Jacob Bauer
Member of Board of Directors
IMVT ·
Immunovant, Inc.
the Board appointed Robert Susman and Jacob Bauer to fill the vacancies on the Board created by the departure of each of Dr. Salzmann and Mr. Migausky
Departed
Peter Salzmann
Chief Executive Officer
IMVT ·
Immunovant, Inc.
Peter Salzmann, M.D. retired from his roles as the Chief Executive Officer and principal executive officer of Immunovant, Inc. (the "Company" or "Immunovant"), effective April 20, 2025
Departed
George Migausky
Member of Board of Directors
IMVT ·
Immunovant, Inc.
On April 18, 2025, George Migausky, a member of Immunovant’s Board and Chair of the Audit Committee of the Board (the “Audit Committee”), resigned from the Board and the Audit Committee, effective immediately.
Departed
Renee Barnett
Chief Financial Officer
IMVT ·
Immunovant, Inc.
Also effective April 20, 2025, Renee Barnett ceased serving as the Chief Financial Officer (including the principal financial officer and principal accounting officer) of the Company.
Role change
Melissa Baird
Chief Operating Officer
HIMS ·
Hims & Hers Health, Inc.
Melissa Baird, Chief Operating Officer of Hims & Hers Health, Inc. (the “Company”), announced her intention to transition into an advisory role with Hims & Hers in the coming months.
Departed
Troy Vanke
Chief Accounting Officer
PLTK ·
Playtika Holding Corp.
On April 17, 2025, Troy Vanke, Chief Accounting Officer of Playtika Holding Corp. (the “Company”), informed the Company of his intent to retire and to resign from his position, effective June 30, 2025.
Role change
Jost Fisher
Interim President and Chief Executive Officer
AEON ·
AEON Biopharma, Inc.
Jost Fisher will step down as Interim President and Chief Executive Officer but will continue to serve as chairman of the Board, a member of the audit committee and chair of the compensation committee.
Appointed
Robert Bancroft
Chief Executive Officer, President and Principal Executive Officer
AEON ·
AEON Biopharma, Inc.
On April 19, 2025, the board of directors (the “Board”) of AEON BioPharma, Inc. (the “Company”) appointed Robert Bancroft, age 60, as the Company’s Principal Executive Officer, President, Chief Executive Officer and member of the Board to serve as a Class I director, effective as of April 29, 2025.
Appointed
Steven C. Crouse
Director
OABI ·
OmniAb, Inc.
the Board appointed Steven C. Crouse and Philip J. Gotwals, Ph.D. to the Board
Appointed
Philip J. Gotwals
Director
OABI ·
OmniAb, Inc.
the Board appointed Steven C. Crouse and Philip J. Gotwals, Ph.D. to the Board
Appointed
Aidan Gomez
Class II director
RIVN ·
Rivian Automotive, Inc. / DE
On April 21, 2025, the Board of Directors (the "Board") of Rivian Automotive, Inc. (the "Company") increased the size of the Board and elected Aidan Gomez to serve as a Class II director of the Company with a term expiring at the 2026 annual meeting of stockholders, effective immediately.
Appointed
Patrick "Kip" Huffman
Senior Vice President and Chief Accounting Officer
BHRB ·
Burke & Herbert Financial Services Corp.
On April 21, 2025, Burke & Herbert Financial Services Corp. (the “Company”) announced the appointment of Patrick “Kip” Huffman, CPA, as Senior Vice President and Chief Accounting Officer.
Role change
Dean Y. Shigemura
Internal Consultant
BOH ·
BANK OF HAWAII CORP
Effective July 1, 2025, Mr. Shigemura will assume the position of Internal Consultant to the Company for one year at an annual salary of $500,000.
Departed
Dean Y. Shigemura
Chief Financial Officer
BOH ·
BANK OF HAWAII CORP
Vice Chair and Chief Financial Officer (“CFO”) Dean Y. Shigemura, 61, will step down as CFO effective June 30, 2025.
Appointed
Bradley S. Satenberg
Chief Financial Officer
BOH ·
BANK OF HAWAII CORP
When Mr. Shigemura exits his current role, his duties as CFO will be assumed by current Senior Executive Vice President and Deputy CFO Bradley S. Satenberg.
Departed
Greg Petersen
Director
PSTV ·
PLUS THERAPEUTICS, INC.
On April 18, 2025, Mr. Greg Petersen resigned as a member of the Board. Mr. Petersen informed the Company that his resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
Appointed
Kyle Guse
Director
PSTV ·
PLUS THERAPEUTICS, INC.
On April 18, 2025, the Board of Directors (the “Board”) of Plus Therapeutics, Inc (the “Company”) unanimously appointed Mr. Kyle Guse to serve as a director of the Board, effective immediately.
Departed
Robert Hofmeister
director
TCRT ·
Alaunos Therapeutics, Inc.
Robert Hofmeister, Ph.D. Resignation On April 15, 2025, Dr. Hofmeister resigned as a member of the board of directors (the “Board”) of Alaunos Therapeutics, Inc. (the “Company”) with immediate effect.
Appointed
Brian Baker
Chief Financial Officer
DYNATRONICS CORP
In connection with Mr. Ellwein's resignation, the Company's Board of Directors has appointed Brian Baker as Chief Financial Officer (principal financial officer and principal accounting officer) of the Company, effective as of May 9, 2025.
Departed
Gabe Ellwein
Chief Financial Officer
DYNATRONICS CORP
On April 15, 2025 Gabe Ellwein informed Dynatronics Corporation (the "Company") of his decision to resign as Chief Financial Officer (principal financial officer and principal accounting officer) of the Company, effective as of May 9, 2025, to pursue other professional interests.
Appointed
Eric Maire
Independent Director
HMMR ·
HAMMER TECHNOLOGY HOLDINGS CORP.
On April 4, 2025, the Board of Directors of the Company voted unanimously to appoint Eric Maire to the Board as an Independent Director.
Departed
Robert E. Knowling Jr.
Director
LRN ·
Stride, Inc.
On April 15, 2025, Robert E. Knowling Jr. notified the Board of Directors (the “Board”) of Stride, Inc. (the “Company”) of his decision to resign from the Board and all committees on which he served, effective immediately.
Departed
Eric P. Palmer
Executive Vice President for Enterprise Strategy, The Cigna Group and President and Chief Executive Officer, Evernorth Health Services
CI ·
Cigna Group
On March 13, 2025, The Cigna Group (the “Company”) filed a Form 8-K disclosing that the employment of Eric P. Palmer, Executive Vice President for Enterprise Strategy, The Cigna Group and President and Chief Executive Officer, Evernorth Health Services, will end April 26, 2025.
Departed
Kristin L. Oliver
Chief Legal Officer, Chief Human Resources Officer, and Executive Vice President of Communications
Hanesbrands Inc.
On April 15, 2025, Kristin L. Oliver, Chief Legal Officer, Chief Human Resources Officer, and Executive Vice President of Communications of Hanesbrands Inc. (the “Company”), notified the Company that she intends to leave the Company to pursue another business opportunity, effective May 9, 2025.
Departed
Craig Fraser
Director
WINT ·
WINDTREE THERAPEUTICS INC /DE/
On April 17, 2025, Mr. Fraser notified the Windtree Therapeutics, Inc.(the “ Company ”) Board of Directors (the “ Board ”) of his resignation from the Board, effective immediately.
Role change
William Dellal
Vice President and Chief Financial Officer
TWO ·
TWO HARBORS INVESTMENT CORP.
On April 18, 2025, the Board of Directors of Two Harbors Investment Corp. (the “Company”) confirmed that William Dellal has been designated as the Company’s Vice President and Chief Financial Officer and will serve in such role until further notice.
Departed
Frances P. Philip
Lead Independent Director
VRA ·
Vera Bradley, Inc.
On April 18, 2025, Vera Bradley, Inc. (the “Company”) announced that long-time board member Frances P. Philip will not stand for re-election at the upcoming 2025 Shareholder Meeting.
Appointed
John Henry IV
director
JUVF ·
JUNIATA VALLEY FINANCIAL CORP
The Board of Directors of Juniata Valley Financial Corp. (the “Company”) appointed John Henry IV as a director of the Company on April 15, 2025.
Appointed
David Pacitti
Chief Executive Officer
AVNS ·
AVANOS MEDICAL, INC.
On March 17, 2025, Avanos Medical, Inc. (the “Company”) announced the appointment of David Pacitti as the Company’s Chief Executive Officer, effective April 14, 2025.
Departed
(interim)
Warren J. Machan
Interim Chief Financial Officer
AVNS ·
AVANOS MEDICAL, INC.
Mr. Machan no longer serves as the Company’s Interim Chief Financial Officer effective April 14, 2025
Appointed
(interim)
Jason M. Pickett
Interim Chief Financial Officer and Treasurer
AVNS ·
AVANOS MEDICAL, INC.
The Company has appointed Jason M. Pickett as Interim Chief Financial Officer and Treasurer, effective April 14, 2025.
Departed
Michael C. Greiner
Senior Vice President and Chief Financial Officer
AVNS ·
AVANOS MEDICAL, INC.
On April 18, 2025, Michael C. Greiner announced that he will leave Avanos Medical, Inc. (the “Company”) to pursue other opportunities because the Company did not offer him a position comparable to the one he held prior to his role as the Company’s Interim Chief Executive Officer.
Departed
Jennifer Prince
Director
SST ·
System1, Inc.
On April 15, 2025,Dexter Fowler and Jennifer Prince notified the Board of Directors (the “Board”) of System1, Inc. (the “Company”) of their respective resignation from the Board, effective as of the close of business on April 15, 2025.
Departed
Dexter Fowler
Director
SST ·
System1, Inc.
On April 15, 2025,Dexter Fowler and Jennifer Prince notified the Board of Directors (the “Board”) of System1, Inc. (the “Company”) of their respective resignation from the Board, effective as of the close of business on April 15, 2025.
Appointed
Theo Davies
Chief Revenue Officer
SSGC ·
SafeSpace Global Corp
On April 17, 2025, we appointed Mr. Theo Davies, as our Chief Revenue Officer (CRO), effective immediately.
Appointed
Yeleussiz Dyussimbekov
Independent Director
USDW ·
MADE IN USA INC.
On April 17, 2025, a new independent director was appointed as member of the Board of Directors (the “Board”) of Alixo-Yolloo Corporation (the “Company”).
Departed
William C. Mulligan
director
UEIC ·
UNIVERSAL ELECTRONICS INC
On April 15, 2025, Messrs. William C. Mulligan and Edward K. Zinser announced their intention to not stand for re-election at the 2026 Annual Meeting.
Appointed
John Mutch
director
UEIC ·
UNIVERSAL ELECTRONICS INC
On April 15, 2025, the Board of Directors (the “Board”) of Universal Electronics Inc. (“UEI” or the “Company”) appointed John Mutch as a director, effective immediately, to fill a vacancy.
Departed
Edward K. Zinser
director
UEIC ·
UNIVERSAL ELECTRONICS INC
On April 15, 2025, Messrs. William C. Mulligan and Edward K. Zinser announced their intention to not stand for re-election at the 2026 Annual Meeting.
Appointed
Evan T. Scott
Chief Financial Officer
LMT ·
LOCKHEED MARTIN CORP
Evan T. Scott has been appointed Chief Financial Officer to replace Mr. Malave effective April 17, 2025.
Departed
Jay Malave
Chief Financial Officer
LMT ·
LOCKHEED MARTIN CORP
Jay Malave, its Chief Financial Officer, advised the Company of his intention to pursue other opportunities outside of the Company.
Appointed
David Davis
President and Chief Executive Officer
FLYYQ ·
Spirit Aviation Holdings, Inc.
On April 17, 2025, Spirit Aviation Holdings, Inc. (“Spirit” or the “Company”) announced the appointment of David Davis as President, Chief Executive Officer of the Company and as a member of the Board of Directors of the Company (the “Board”), in each case to be effective April 21, 2025.
Role change
(interim)
Patrick Goris
interim Controller
CARR ·
CARRIER GLOBAL Corp
On April 16, 2025, Patrick Goris, Senior Vice President and Chief Financial Officer of the Company, agreed to become interim Controller of the Company, effective May 2, 2025, while a search for a permanent replacement is conducted.
Departed
Kyle Crockett
Vice President, Controller and Chief Accounting Officer
CARR ·
CARRIER GLOBAL Corp
On April 16, 2025, Kyle Crockett, Vice President, Controller and Chief Accounting Officer of Carrier Global Corporation (the “Company”), informed the Company that he is resigning to pursue another opportunity.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.